Clinical evolution

© Getty Images

Interview: The evolution of data management in clinical development

By Liza Laws

Gen Li is president and founder of Phesi, and OSP was delighted to speak to him to discuss the evolution of data management in clinical development and how intelligent data use can reduce clinical trial cancellations, minimise protocol amendments, and...

© Getty Images

Five decentralized clinical trial organizations raising big VC cash

By Jonathan Smith

Decentralized clinical trials (DCTs) are gaining increasing interest as they have the potential to make clinical trial operations quicker, more efficient and more accessible to patients. Check out five DCT organizations that have raised big venture capital...

© Getty Images

FDA approval expands Welireg to patients with renal cell carcinoma

By Jonathan Smith

The oral treatment belzutifan, developed by MSD (known as Merck in the US) and branded as Welireg, has received the green light from the US Food and Drug Administration (FDA) for the treatment of an advanced form of renal cell carcinoma (RCC).

© Getty Images

Interview: Gen AI in life sciences - sorting the hype from the hope

By Liza Laws

The Gen AI revolution promises to redefine various industries, with the life sciences sector at the forefront of this transformation. OSP had the chance to speak to Tarun Mathur, CEO at Indegene, who was keen to allay many of the fears those in the industry...